Clinical Practice

Use the tool below to view all available Global Neurology Academy Series

NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiers
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
CME/CE
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
0.50 credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
0.50 credits
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiers
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne Schindler, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John F. Brandsema, MD
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD